These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 2504597

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. In vitro and in vivo activities of DN-9550, a new broad-spectrum cephalosporin.
    Une T, Otani T, Sato M, Ikeuchi T, Osada Y, Ogawa H, Sato K, Mitsuhashi S.
    Antimicrob Agents Chemother; 1985 Apr; 27(4):473-8. PubMed ID: 3873898
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Antibacterial properties of Ro 40-6890, a broad-spectrum cephalosporin, and its novel orally absorbable ester, Ro 41-3399.
    Angehrn P, Hohl P, Hubschwerlen C, Page M, Then R.
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2825-34. PubMed ID: 1482153
    [Abstract] [Full Text] [Related]

  • 25. Comparable evaluation of orally active beta-lactam compounds in ampicillin-resistant gram-positive and gram-negative rods: role of beta-lactamases on resistance.
    Cullmann W, Dick W, Stieglitz M, Opferkuch W.
    Chemotherapy; 1988 Dec; 34(3):202-15. PubMed ID: 3262045
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Ways to overcome cephalosporinase-mediated beta-lactam resistance in Enterobacter cloacae.
    Then RL, Angehrn P.
    Chemioterapia; 1985 Feb; 4(1):83-9. PubMed ID: 3872727
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Mechanism of action of the new orally active cephalosporin FK027.
    Shigi Y, Matsumoto Y, Kaizu M, Fujishita Y, Kojo H.
    J Antibiot (Tokyo); 1984 Jul; 37(7):790-6. PubMed ID: 6381449
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. In vitro activity of cefpodoxime in comparison with other oral beta-lactam antibiotics.
    Kayser FH.
    Infection; 1994 Jul; 22(5):370-5. PubMed ID: 7843823
    [Abstract] [Full Text] [Related]

  • 39. [In vitro activity of cefetamet compared with other antimicrobial agents against bacteria isolated from respiratory tract infections].
    Mendes CM.
    Rev Assoc Med Bras (1992); 1997 Jul; 43(1):47-52. PubMed ID: 9224992
    [Abstract] [Full Text] [Related]

  • 40. In vitro activity of cefetamet against enterobacteria expressing an SHV-5-type beta-lactamase.
    Tzouvelekis LS, Prinarakis EE, Gazouli M, Miriagou V, Tzelepi E, Legakis NJ.
    Chemotherapy; 1996 Jul; 42(5):324-8. PubMed ID: 8874970
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.